Details for Patent: 11,583,216
✉ Email this page to a colleague
Which drugs does patent 11,583,216 protect, and when does it expire?
Patent 11,583,216 protects SOTALOL HYDROCHLORIDE and is included in one NDA.
Summary for Patent: 11,583,216
| Title: | Method of administering sotalol IV/switch |
| Abstract: | Embodiments of the invention are broadly drawn to methods for determining an optimum dose of an antiarrhythmic drug, for example sotalol. In particular, the method involves titrating the dose of the drug gradually to determine the optimum plasma concentration for a patient, whether the patient has normal or abnormal renal function. |
| Inventor(s): | Vijay Ivaturi, Jogarao Gobburu |
| Assignee: | University of Maryland Baltimore |
| Application Number: | US17/003,297 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 11,583,216
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altathera Pharms Llc | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | SOLUTION;INTRAVENOUS | 022306-001 | Jul 2, 2009 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | INTRAVENOUS SOTALOL DOSING REGIMEN FOR USE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
